China · Delayed Price · Currency is CNY Youngy Health Statistics
Total Valuation
Youngy Health has a market cap or net worth of CNY 2.60 billion. The enterprise value is 2.29 billion.
| Market Cap | 2.60B |
| Enterprise Value | 2.29B |
Important Dates
The last earnings date was Wednesday, October 28, 2026.
| Earnings Date | Oct 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Youngy Health has 804.04 million shares outstanding. The number of shares has increased by 6.35% in one year.
| Current Share Class | 804.04M |
| Shares Outstanding | 804.04M |
| Shares Change (YoY) | +6.35% |
| Shares Change (QoQ) | +0.03% |
| Owned by Insiders (%) | 1.60% |
| Owned by Institutions (%) | 1.38% |
| Float | 670.73M |
Valuation Ratios
The trailing PE ratio is 38.41.
| PE Ratio | 38.41 |
| Forward PE | n/a |
| PS Ratio | 2.96 |
| PB Ratio | 2.00 |
| P/TBV Ratio | 2.26 |
| P/FCF Ratio | 95.22 |
| P/OCF Ratio | 61.42 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.99, with an EV/FCF ratio of 83.91.
| EV / Earnings | 32.77 |
| EV / Sales | 2.61 |
| EV / EBITDA | 11.99 |
| EV / EBIT | 14.06 |
| EV / FCF | 83.91 |
Financial Position
The company has a current ratio of 5.43, with a Debt / Equity ratio of 0.06.
| Current Ratio | 5.43 |
| Quick Ratio | 2.54 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | 0.39 |
| Debt / FCF | 2.70 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 8.81% and return on invested capital (ROIC) is 13.98%.
| Return on Equity (ROE) | 8.81% |
| Return on Assets (ROA) | 6.58% |
| Return on Invested Capital (ROIC) | 13.98% |
| Return on Capital Employed (ROCE) | 11.73% |
| Weighted Average Cost of Capital (WACC) | 5.54% |
| Revenue Per Employee | 1.54M |
| Profits Per Employee | 122,737 |
| Employee Count | 569 |
| Asset Turnover | 0.57 |
| Inventory Turnover | 1.68 |
Taxes
In the past 12 months, Youngy Health has paid 64.08 million in taxes.
| Income Tax | 64.08M |
| Effective Tax Rate | 36.51% |
Stock Price Statistics
The stock price has decreased by -28.54% in the last 52 weeks. The beta is 0.26, so Youngy Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.26 |
| 52-Week Price Change | -28.54% |
| 50-Day Moving Average | 3.65 |
| 200-Day Moving Average | 4.27 |
| Relative Strength Index (RSI) | 28.60 |
| Average Volume (20 Days) | 10,929,434 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Youngy Health had revenue of CNY 876.63 million and earned 69.84 million in profits. Earnings per share was 0.08.
| Revenue | 876.63M |
| Gross Profit | 376.90M |
| Operating Income | 162.80M |
| Pretax Income | 175.51M |
| Net Income | 69.84M |
| EBITDA | 178.54M |
| EBIT | 162.80M |
| Earnings Per Share (EPS) | 0.08 |
Balance Sheet
The company has 493.58 million in cash and 73.69 million in debt, with a net cash position of 419.88 million or 0.52 per share.
| Cash & Cash Equivalents | 493.58M |
| Total Debt | 73.69M |
| Net Cash | 419.88M |
| Net Cash Per Share | 0.52 |
| Equity (Book Value) | 1.30B |
| Book Value Per Share | 1.48 |
| Working Capital | 979.62M |
Cash Flow
In the last 12 months, operating cash flow was 42.28 million and capital expenditures -15.01 million, giving a free cash flow of 27.27 million.
| Operating Cash Flow | 42.28M |
| Capital Expenditures | -15.01M |
| Depreciation & Amortization | 15.74M |
| Net Borrowing | -11.13M |
| Free Cash Flow | 27.27M |
| FCF Per Share | 0.03 |
Margins
Gross margin is 42.99%, with operating and profit margins of 18.57% and 7.97%.
| Gross Margin | 42.99% |
| Operating Margin | 18.57% |
| Pretax Margin | 20.02% |
| Profit Margin | 7.97% |
| EBITDA Margin | 20.37% |
| EBIT Margin | 18.57% |
| FCF Margin | 3.11% |
Dividends & Yields
Youngy Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -6.35% |
| Shareholder Yield | -6.35% |
| Earnings Yield | 2.60% |
| FCF Yield | 1.05% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on April 29, 2016. It was a forward split with a ratio of 2.
| Last Split Date | Apr 29, 2016 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |